SCHEMBL26418969

SCHEMBL26418969

CCOc1ccc(C(=O)Oc2ccc(OC(=O)c3ccc(OC(C)(C)C)cc3)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.61
▸ CCNC P24863 1/20 0.56
▸ CDK8 P49336 1/20 0.56
▸ LMNA P02545 3/20 0.54
▸ PARP10 Q53GL7 1/20 0.51
▸ MAPT P10636 3/20 0.51
▸ THRB P10828 1/20 0.51
▸ NPC1 O15118 2/20 0.49
▸ PLK1 P53350 1/20 0.49
▸ ALDH1A1 P00352 2/20 0.48
▸ SCN1A P35498 1/20 0.48
▸ SCN2A Q99250 1/20 0.48
▸ SCN3A Q9NY46 1/20 0.48
▸ PRSS1 P07477 1/20 0.47
▸ ACR P10323 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2455357 0.88 KMT2A (0.73) KMT2ACCNCCDK8LMNAPARP10
SCHEMBL9905987 0.88 KMT2A (0.73) KMT2ACCNCCDK8LMNAPARP10
SCHEMBL12736338 0.83 KMT2A (0.68) KMT2ACCNCCDK8LMNAPARP10
SCHEMBL11943005 0.83 KMT2A (0.68) KMT2ACCNCCDK8LMNAPARP10
SCHEMBL11768997 0.83 KMT2A (0.72) KMT2ACCNCCDK8LMNAPARP10
SCHEMBL19604068 0.82 LMNA (0.60) KMT2ALMNAPARP10MAPTALDH1A1
SCHEMBL19599191 0.82 PRSS1 (0.56) KMT2ALMNAMAPTNPC1ALDH1A1
SCHEMBL10624035 0.82 KMT2A (0.66) KMT2ACCNCCDK8LMNAPARP10
SCHEMBL5706026 0.82 CCNC (0.68) KMT2ACCNCCDK8LMNAPARP10
SCHEMBL11672649 0.82 PLA2G4B (0.68) KMT2ACCNCCDK8LMNAPARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11781070-B2 Mesogen compounds TRANSITIONS OPTICAL, LTD. (IE) 2023-10-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11781070-B2 Mesogen compounds MDN1, LSG1, MNS1 KMT2A 3315/4885CCNC 95/4885CDK8 754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback